L3VLUP
ProSign in

SRPT in the 13F filings

Sarepta Therapeutics Inc · CUSIP 803607100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
14 Feb 2024
latest of these filings; the earliest 12 Feb 2024
Managers listing it
12
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 11 listed it in both
Shares listed
13,270,177
combined, among listed positions
Reported value
$1.3bn
combined, at the quarter end

Among the 93 comparable managers: 6 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing SRPT in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

12 of 12 holders

ActionFiling
Janus Henderson Group Ltd5,345,785$515m0.31%Trimmed-436,66414 Feb 2024 (the filing on sec.gov)
Wellington Management Group LLP4,127,610$398m0.07%Added+217,81012 Feb 2024 (the filing on sec.gov)
Farallon Capital Management LLC1,210,073$117m0.53%Trimmed-165,12714 Feb 2024 (the filing on sec.gov)
Two Sigma Advisers LP706,134$68m0.16%Trimmed-314,80014 Feb 2024 (the filing on sec.gov)
Renaissance Technologies LLC562,978$54m0.08%Trimmed-119,90013 Feb 2024 (the filing on sec.gov)
Balyasny Asset Management LLC498,829$48m0.09%Added+278,40414 Feb 2024 (the filing on sec.gov)
Voloridge Investment Management LLC358,548$35m0.14%Added+260,56914 Feb 2024 (the filing on sec.gov)
Two Sigma Investments LP302,340$29m0.07%Trimmed-508,12714 Feb 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP88,208$8.5m0.05%Added+43,20814 Feb 2024 (the filing on sec.gov)
PDT Partners LLC35,225$3.4m0.38%Newnew14 Feb 2024 (the filing on sec.gov)
Bridgewater Associates LP26,388$2.5munder 0.1%Trimmed-24,07614 Feb 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP8,059$777kunder 0.1%Added+6,18414 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (4)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
SRPT by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$52mn.a.n.a.
Q3 20133$62mn.a.n.a.
Q4 20131$4.7mn.a.n.a.
Q1 20141$601kn.a.n.a.
Q2 20143$68mn.a.n.a.
Q3 20142$12mn.a.n.a.
Q4 20141$22mn.a.n.a.
Q1 20151$23mn.a.n.a.
Q2 20152$31mn.a.n.a.
Q3 20155$74mn.a.n.a.
Q4 20152$129mn.a.n.a.
Q1 20161$58mn.a.n.a.
Q2 20163$62mn.a.n.a.
Q3 201610$425mn.a.n.a.
Q4 20165$48mn.a.n.a.
Q1 20176$58mn.a.n.a.
Q2 20174$123mn.a.n.a.
Q3 20176$239mn.a.n.a.
Q4 20178$150mn.a.n.a.
Q1 20188$1.1bnn.a.n.a.
Q2 201820$2.6bnn.a.n.a.
Q3 201810$2.6bnn.a.n.a.
Q4 201813$2.1bnn.a.n.a.
Q1 201911$2.4bnn.a.n.a.
Q2 201911$2.9bnn.a.n.a.
Q3 20198$1.2bnn.a.n.a.
Q4 20199$2.5bnn.a.n.a.
Q1 202011$2.0bnn.a.n.a.
Q2 202016$3.6bnn.a.n.a.
Q3 202011$3.1bnn.a.n.a.
Q4 202013$4.0bnn.a.n.a.
Q1 202111$1.3bnn.a.n.a.
Q2 20219$1.0bnn.a.n.a.
Q3 202110$1.2bnn.a.n.a.
Q4 202113$1.2bnn.a.n.a.
Q1 202212$1.1bnn.a.n.a.
Q2 202213$946mn.a.n.a.
Q3 202221$1.8bnn.a.n.a.
Q4 202221$1.9bnn.a.n.a.
Q1 202320$2.3bnn.a.n.a.
Q2 202313$1.8bnn.a.n.a.
Q3 202319$2.1bnn.a.n.a.
Q4 202312$1.3bn610
Q1 202415$2.0bn95
Q2 202415$2.0bn89
Q3 202412$1.4bn75
Q4 20249$1.2bn45
Q1 202511$665m93
Q2 20255$175m51
Q3 20256$164m23
Q4 20257$298m1615
Q1 20265$281m1811
Q2 20265$132m1416

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

SRPT and LLY →SRPT and JNJ →SRPT and VRTX →Choose a stock to compare with SRPT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own SRPT, latest filings →Back to the 13F Explorer →